Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-4846
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumm, Elena J.-
dc.contributor.authorPagel, Oliver-
dc.contributor.authorGambaryan, Stepan-
dc.contributor.authorWalter, Ulrich-
dc.contributor.authorZahedi, René P.-
dc.contributor.authorSmolenski, Albert-
dc.contributor.authorJurk, Kerstin-
dc.date.accessioned2020-06-10T12:24:21Z-
dc.date.available2020-06-10T14:24:21Z-
dc.date.issued2020-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/4848-
dc.description.abstractThe cell cycle is controlled by microtubule-associated serine/threonine kinase-like (MASTL), which phosphorylates the cAMP-regulated phosphoproteins 19 (ARPP19) at S62 and 19e/α-endosulfine (ENSA) at S67and converts them into protein phosphatase 2A (PP2A) inhibitors. Based on initial proteomic data, we hypothesized that the MASTL-ENSA/ARPP19-PP2A pathway, unknown until now in platelets, is regulated and functional in these anucleate cells. We detected ENSA, ARPP19 and various PP2A subunits (including seven different PP2A B-subunits) in proteomic studies of human platelets. ENSA-S109/ARPP19–S104 were efficiently phosphorylated in platelets treated with cAMP- (iloprost) and cGMP-elevating (NO donors/riociguat) agents. ENSA-S67/ARPP19-S62 phosphorylations increased following PP2A inhibition by okadaic acid (OA) in intact and lysed platelets indicating the presence of MASTL or a related protein kinase in human platelets. These data were validated with recombinant ENSA/ARPP19 and phospho-mutants using recombinant MASTL, protein kinase A and G. Both ARPP19 phosphorylation sites S62/S104 were dephosphorylated by platelet PP2A, but only S62-phosphorylated ARPP19 acted as PP2A inhibitor. Low-dose OA treatment of platelets caused PP2A inhibition, diminished thrombin-stimulated platelet aggregation and increased phosphorylation of distinct sites of VASP, Akt, p38 and ERK1/2 MAP kinases. In summary, our data establish the entire MASTL(like)–ENSA/ARPP19–PP2A pathway in human platelets and important interactions with the PKA, MAPK and PI3K/Akt systems. Keywords: platelets; serine/threonine protein phosphatases; cyclic AMP; cyclic GMP; ENSA; ARPP19; MAP kinaseen_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizin-
dc.language.isoeng-
dc.rightsCC BYde_DE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleThe cell cycle checkpoint system MAST(L)-ENSA/ARPP19-PP2A is targeted by cAMP/PKA and cGMP/PKG in anucleate human plateletsen_GB
dc.typeZeitschriftenaufsatzde_DE
dc.identifier.urnurn:nbn:de:hebis:77-publ-598652-
dc.identifier.doihttp://doi.org/10.25358/openscience-4846-
jgu.type.dinitypearticle-
jgu.type.versionPublished versionen_GB
jgu.type.resourceText-
jgu.organisation.departmentFB 04 Medizin-
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleCells-
jgu.journal.volume9-
jgu.journal.issue2-
jgu.pages.alternativeArt. 472-
jgu.publisher.year2020-
jgu.publisher.nameMDPI-
jgu.publisher.placeBasel-
jgu.publisher.urihttp://dx.doi.org/10.3390/cells9020472-
jgu.publisher.issn2073-4409-
jgu.organisation.placeMainz-
jgu.subject.ddccode610-
opus.date.accessioned2020-06-10T12:24:21Z-
opus.date.modified2020-06-24T10:46:59Z-
opus.date.available2020-06-10T14:24:21-
opus.subject.dfgcode00-000-
opus.organisation.stringFB 04: Medizin: Centrum für Thrombose und Hämostase (CTH)de_DE
opus.identifier.opusid59865-
opus.institute.number0463-
opus.metadataonlyfalse-
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_GB
opus.affiliatedKumm, Elena J.-
opus.affiliatedWalter, Ulrich-
opus.affiliatedJurk, Kerstin-
jgu.publisher.doi10.3390/cells9020472
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
59865.pdf3.46 MBAdobe PDFView/Open